Page 66 - 《食品科学技术学报》2020年第4期

第 38 卷 第 4 期摇 摇 摇 摇 摇 摇 步摇 营等: 基于分子对接技术从虾夷扇贝中筛选抗 SARS鄄CoV鄄2 活性肽研究 6 1

novel coronavirus from the ongoing Wuhan outbreak and MA J, HUO X Q, CHEN Q, et al. Study on screening
modeling of its spike protein for risk of human transmis鄄 Chinese traditional medicine against SARS鄄CoV鄄2 based
sion[J]. Science China Life Sciences, 2020, 63(3): on Mpro and PLP[J]. China Journal of Chinese Materia
457 - 460. Medica, 2020, 45(6):1219 - 1224.
[11] 摇 LI Y, ZHANG J Y, WANG N, et al. The rapeutic [16]摇 宗阳, 丁美林, 贾可可, 等. 基于网络药理学和分子
drugs targeting 2019鄄nCoV main protease by high鄄 对接法探寻达原饮治疗新型冠状病毒肺炎(COVID鄄
throughput screening[ J/ OL]. bioRxiv, 2020. [2020鄄 19)活性化合物的研究[J]. 中草药, 2020, 51(4):
06鄄08]. https:椅doi. org/ 10.1101/ 2020.01.28.922922. 836 - 844.
[12]摇 莫立乾, 郑萍. 新型冠状病毒肺炎治疗药物:磷酸氯 ZONG Y, DING M L, JIA K K, et al. Exploring the
喹[J]. 南方医科大学学报, 2020, 40(4): 586 - 594. active compounds of Da鄄Yuan鄄Yin in treatment of novel
MO L Q, ZHENG P. Chloroquine phosphate: the coronavirus (2019鄄nCoV) pneumonia based on network
rapeutic drug for COVID鄄19 [ J]. Journal of Southern pharmacology and molecular docking method[J]. Tradi鄄
Medical University, 2020, 40(4): 586 - 594. tional and Herbal Drugs, 2020, 51(4):836 - 844.
[13]摇 孙逊, 陶嘉磊, 许少菊, 等. 基于网络药理学探究化 [17]摇 YU Z P, WU S J, ZHAO W Z, et al. Identification and
湿败毒方治疗新型冠状病毒肺炎的分子机制[J/ OL]. the molecular mechanism of a novel myosin鄄derived ACE
中药材, 2020. [2020鄄06鄄08]. http:椅kns. cnki. net/ inhibitory peptide [J]. Food & Function, 2018, 9(1):
kcms/ detail/ 44.1286. R.20200430.1759.006. html. 364 - 370.
SUN X, TAO J L, XU S J, et al. The molecular mecha鄄 [18]摇 TIAN X L, LI C, HUANG A L, et al. Potent binding of
nism of treating COVID鄄19 with Huashi Baidu formula 2019 novel coronavirus spike protein by a SARS corona鄄
based on network pharmacology [ J/ OL]. Journal of virus鄄specific human monoclonal antibody [ J]. Emerg
Chinese Medicinal Materials, 2020. [ 2020鄄06鄄08 ]. Microbes Infect, 2020, 9(1): 382 - 385.
http:椅kns. cnki. net/ kcms/ detail/ 44. 1286. R. 20200430. [19]摇 LEI C H, FU W Y, QIAN K W, et al. Potent neutral鄄
1759.006. html. ization of 2019 novel coronavirus by recombinant ACE2鄄
[14]摇 邓燕君, 刘博文, 贺桢翔, 等. 基于网络药理学和分 Ig [ J/ OL]. bioRxiv,2020. [2020鄄06鄄08]. https:椅
子对接法探索藿香正气口服液预防新型冠状病毒肺 www. biorxiv. org/ content/ 10.1101/ 2020.02.01.929976v2.
炎(COVID鄄19)活性化合物研究[J]. 中草药, 2020, [20]摇 LIU X, WANG X J. Potential inhibitors for 2019鄄n CoV
51(5):1113 - 1122. coronavirus M protease from clinically approved medi鄄
DENG Y J, LIU B W, HE Z X, et al. Study on active cines [J/ OL]. bioRxiv, 2020. [2020鄄06鄄08]. https:椅
compounds from Huoxiang Zhengqi oral liquid for pre鄄 www. biorxiv. org/ content/ 10.1101/ 2020.01.29.924100v1.
vention of coronavirus disease 2019 (COVID鄄19) based [21]摇 沈亮亮, 李勇, 周明, 等. 基于分子对接技术筛选抗
on network pharmacology and molecular docking [ J]. 严重急性呼吸综合征冠状病毒 2 中药小分子化合物
Chinese Traditional and Herbal Drugs, 2020, 51(5): [J]. 中国新药杂志, 2020, 29(7):773 - 781.
1113 - 1122. SHEN L L, LI Y, ZHOU M, et al. Screening of anti鄄
[15]摇 马婧,霍晓乾,陈茜,等. 基于 Mpro 和 PLP 筛选潜在 SARS鄄CoV鄄2 small molecular compounds from traditional
抗新型冠状病毒中药研究[J]. 中国中药杂志,2020, Chinese medicine based on molecular docking[J]. Chi鄄
45(6):1219 - 1224. nese Journal of New Drugs, 2020, 29(7):773 - 781.

Screening Research of Anti鄄SARS鄄CoV鄄2 Peptides from
Mizuhopecten yessoensis Based on Molecular Docking

1 1 1,2 1,* 1
BU Ying ,摇 HE Wei ,摇 WANG Fei ,摇 ZHU Wenhui ,摇 LI Xuepeng ,摇
1 1 1,*
YI Shumin ,摇 XU Yongxia ,摇 LI Jianrong
(1. College of Food Science and Technology, Bohai University / National & Local Joint Engineering Research
Center of Storage, Processing and Safety Control Technology for Fresh Agricultural and Aquatic Products/
National R&D Branch Center of Surimi and Surimi Products Processing, Jinzhou 121013, China;
2. Collaborative Innovation Center of Seafood Deep Processing, Dalian Polytechnic University,
Dalian 116034, China)

Abstract: In order to screen bioactive peptides against SARS鄄CoV鄄2 from food raw materials,